June 16, 2026
|
The Honorable Mehmet Oz, M.D.
|
|
RE: Regulatory Relief Coalition Comments on the Proposed Rule Governing Electronic Prior Authorization for Drugs
Dear Administrator Oz:
The undersigned members of the Regulatory Relief Coalition (RRC), representing thousands of physicians throughout the United States, appreciate the opportunity to comment on the Centers on electronic prior authorization (e-PA) for drugs in federal health care programs. RRC is a group of national physician specialty organizations advocating for regulatory burden reduction to ensure that utilization review policies are not a barrier to timely and equitable access to care for the patients we serve.
RRC strongly supports the regulatory changes set forth in the Proposed Rule, which builds on by standardizing e-PA for drugs across all services and payer types. These regulations would significantly reduce barriers to care for patients and lessen provider requirements. Our comments focus on additional modifications and clarifications that will further aid CMS in accomplishing these goals.
